Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-16

Clinical Trial Update: Telmisartan and Amlodipine Versus Monocomponent Tablets [Phase 1]

View source ↗

Summary

Phase 1 trial comparing a telmisartan/amlodipine combination to each monocomponent tablet for hypertension; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Micardis (telmisartan)
  • NORVASC (amlodipine besylate)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 1 | Status: COMPLETED | Results posted: 2012-03-16